These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 20554711

  • 1. The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A.
    Schulte KM, Machens A, Fugazzola L, McGregor A, Diaz-Cano S, Izatt L, Aylwin S, Talat N, Beck-Peccoz P, Dralle H.
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E92-7. PubMed ID: 20554711
    [Abstract] [Full Text] [Related]

  • 2. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW.
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [Abstract] [Full Text] [Related]

  • 3. Coincidence of multiple endocrine neoplasia type 2A with acromegaly.
    Saito T, Miura D, Taguchi M, Takeshita A, Miyakawa M, Takeuchi Y.
    Am J Med Sci; 2010 Oct; 340(4):329-31. PubMed ID: 20739875
    [Abstract] [Full Text] [Related]

  • 4. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL, Zhu SX, Li JJ, Liu JB, Yin M, Xiao BY, Yu CL, Wang LM, Gu LQ, Cui B, Ning G, Li XY, Zhao YJ.
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
    [Abstract] [Full Text] [Related]

  • 5. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF, Martins JM, do Vale S, Dias T, Silveira C, da Silva IR, Carmo-Fonseca M.
    Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
    [Abstract] [Full Text] [Related]

  • 6. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR, Thomas BC, Richards ML, Zhang J, Morris JC.
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [Abstract] [Full Text] [Related]

  • 7. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
    Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
    [Abstract] [Full Text] [Related]

  • 8. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
    Elston MS, Meyer-Rochow GY, Holdaway I, Conaglen JV.
    Horm Metab Res; 2012 May; 44(5):339-42. PubMed ID: 22274720
    [Abstract] [Full Text] [Related]

  • 9. Clinical manifestations of familial medullary thyroid carcinoma.
    Kameyama K, Okinaga H, Takami H.
    Biomed Pharmacother; 2004 May; 58(6-7):348-50. PubMed ID: 15271414
    [Abstract] [Full Text] [Related]

  • 10. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC.
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [Abstract] [Full Text] [Related]

  • 11. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
    Peppa M, Boutati E, Kamakari S, Pikounis V, Peros G, Panayiotides IG, Economopoulos T, Raptis SA, Hadjidakis D.
    Eur J Endocrinol; 2008 Dec; 159(6):767-71. PubMed ID: 18805915
    [Abstract] [Full Text] [Related]

  • 12. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
    Calva D, O'Dorisio TM, Sue O'Dorisio M, Lal G, Sugg S, Weigel RJ, Howe JR.
    Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
    [Abstract] [Full Text] [Related]

  • 13. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP.
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [Abstract] [Full Text] [Related]

  • 14. Multiple endocrine neoplasia type 2A: case report.
    Păun DL, Poiană C, Petriş R, Radian S, Miulescu RD, Constantinescu G, Orban C.
    Chirurgia (Bucur); 2013 Dec; 108(6):900-3. PubMed ID: 24331334
    [Abstract] [Full Text] [Related]

  • 15. Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.
    Valente FO, Dias da Silva MR, Camacho CP, Kunii IS, Bastos AU, da Fonseca CC, Simião HP, Tamanaha R, Maciel RM, Cerutti JM.
    J Endocrinol Invest; 2013 Dec; 36(11):975-81. PubMed ID: 23723040
    [Abstract] [Full Text] [Related]

  • 16. Change in the spectrum of RET mutations diagnosed between 1994 and 2006.
    Frank-Raue K, Rondot S, Schulze E, Raue F.
    Clin Lab; 2007 Dec; 53(5-6):273-82. PubMed ID: 17605401
    [Abstract] [Full Text] [Related]

  • 17. A rare extracellular D631Y germline mutation of the RET proto-oncogene in two Korean families with multiple endocrine neoplasia 2A.
    Bae SJ, Kim DJ, Kim JY, Park SY, Choi SH, Song YD, Ki CS, Chung JH.
    Thyroid; 2006 Jun; 16(6):609-14. PubMed ID: 16839264
    [Abstract] [Full Text] [Related]

  • 18. Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case.
    Hibi Y, Ohye T, Ogawa K, Shimizu Y, Shibata M, Kagawa C, Mizuno Y, Uchino S, Kosugi S, Kurahashi H, Iwase K.
    Surg Today; 2014 Nov; 44(11):2195-200. PubMed ID: 24449023
    [Abstract] [Full Text] [Related]

  • 19. The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.
    Colombo C, Minna E, Rizzetti MG, Romeo P, Lecis D, Persani L, Mondellini P, Pierotti MA, Greco A, Fugazzola L, Borrello MG.
    Orphanet J Rare Dis; 2015 Mar 01; 10():25. PubMed ID: 25887804
    [Abstract] [Full Text] [Related]

  • 20. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL, Gosnell J, Elston MS, Saurine TJ, Richardson AL, Delbridge LW, Aglen JV, Robinson BG.
    Clin Endocrinol (Oxf); 2005 Dec 01; 63(6):636-41. PubMed ID: 16343097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.